Orthofix launches OsteoCove bioactive synthetic graft
October 12, 2023
Orthofix today announced it received FDA 510(k) clearance for its OsteoCove bioactive synthetic graft.
Orthofix today announced it received FDA 510(k) clearance for its OsteoCove bioactive synthetic graft.
Moximed announced today that doctors completed the first commercial cases for its Misha knee system, an implantable shock absorber (ISA).